Hypertension and cognitive function: Pathophysiologic effects of hypertension on the brain

Current Hypertension Reports

Volumn 5, Issue 3, 2003, Pages 255-261

  Manolio, Teri A ^a   Olson, Jean ^b   Longstreth Jr , W T ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AUTOREGULATION; BLOOD PRESSURE REGULATION; BRAIN ATHEROSCLEROSIS; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; COGNITIVE DEFECT; HUMAN; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; MULTIINFARCT DEMENTIA; PATHOPHYSIOLOGY; REVIEW; VASCULAR AMYLOIDOSIS; WHITE MATTER; ATROPHY; BRAIN; BRAIN DISEASE; COGNITION; HOMEOSTASIS; PATHOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; ATROPHY; BRAIN; BRAIN DISEASES; BRAIN INFARCTION; BRAIN ISCHEMIA; COGNITION; DEMENTIA, VASCULAR; HOMEOSTASIS; HUMANS; HYPERTENSION;

EID: 0141688134     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-003-0029-6     Document Type: Review

References (50)

1. Elias MF, Wolf PA, D'Agostino RB, et al.: Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 1993, 138:353-364.
2. Knopman D, Boland LL, Mosley T, et al.: Cardiovascular risk factors and cognitive decline in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study investigators. Neurology 2001, 56:42-48.
3. Zhu L, Viitanen M, Guo Z, et al.: Blood pressure reduction, cardiovascular diseases, and cognitive decline in the Mini-Mental State Examination in a community population of normal very old people: a three-year follow-up. J Clin Epidemiol 1998, 51:385-391.
4. Seux ML, Thijs L, et al.: Correlates of cognitive status of old patients with isolated systolic hypertension: the Syt-Eur Vascular Dementia Project. J Hypertens 1998, 16:963-969.
5. Rigaud AS, Olde-Rikkert MGM, Hanon O, et al.: Antihypertensive drugs and cognitive function. Curr Hypertens Rep 2002, 4:211-215.
6. Walstein SR, Jennings JR, Ryan CM, et al.: Hypertension and neuropsychological performance in men: Interactive effects of age. Health Psychol 1996, 15:102-109.
7. Erkinjuntti T, Subcortical vascular dementia. Cerebrovasc Dis 2002, 13 (Suppl 2):58-60.
8. Desmond DW: Cognition and white matter lesions. Cerebrosc Dis 2002, 13(Suppl 2):53-57.
9. Ross GW, Launer LJ, Petrovitch H, et al.: The association between mid-life blood pressure and dementia: the Honolulu-Asia Aging Study. Neurology 1998, 50:A229.
10. Anstey K, Christensen H: Education, activity, health, blood pressure and apolipoprotein E as predictors of cognitive change in old age: a review. Gerontology 2000, 46:163-177.
11. MacMahon S, Peto R, Cutler J, et al.: Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335:765-774.
12. Collins R, Peto R, MacMahon S, et al.: Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990, 335:827-838.
13. Brown RD, Whisnant JP, Sicks JD, et al.: Stroke incidence, prevalence, and survival. Secular trends in Rochester, Minnesota, through 1989. Stroke 1996, 27:373-380.
14. Cotran RS, Kumar V, Collins T: Robbins Pathologic Basis of Disease, edn 6. Philadelphia: WB Saunders; 1999.
15. Guo Z, Viitnen M, Fratiglioni L, Winblad B: Blood pressure and dementia in the elderly: epidemiologic perspectives. Biomed Pharmacother 1997, 51:68-73.
16. Semplicini A, Maresca A, Sartori M, et al.: Hypertension and cerebrovascular diseases: a specific role of vascular protection for the prevention of dementia. J Cardiovasc Pharmacol 2001, 38(Suppl 2):S79-S82.
17. Mulvany MJ: Small artery remodeling and significance in the development of hypertension. New Physiol Sci 2002, 17:105-109.
18. Kalaria RN: Small vessel disease and Alzheimer's dementia: pathological consideration. Cerebrovasc Dis 2002, 13(Suppl 2):48-52.
19. Wong TY, Klein Sharrett AR, et al.: Retinal Microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke 2002, 33:1487-1492.
20. Kalaria RN: The blood-brain barrier and cerebral microcirculation in Alzheimer disease. Cerebrovasc Brain Metab Rev 1992, 4:226-260.
21. Paulson OB, Standgaard S: Hypertensive disease and cerebral circulation. In Hypertension: Pathophysiology, Diagnosis and Treatment. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995:445-463.
22. Kato H, Izumiyama M, Izumiyama K, et al.: Silent cerebral microbleeds on T2*-weighted MRI; correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke 2002, 33:1536-1540.
23. Kidwell CS, Saver JL, Villablanca JP, et al.: Magnetic resonance imaging detecton of microbleeds before thrombolysis: an emerging application. Stroke 2002, 33:95-98.
24. Pantoni L, Garcia JH: The significance of cerebral white matter abnormalities 100 years after Binswanger's report: a review. Stroke 1995, 26:1293-1301.
25. Manolio TA, Furberg CD: Age as a predictor of outcome: what role does it play? Am J Med 1992, 92:1-6.
26. Longstreth WT Jr, Manolio TA, Arnold A, et al.: Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health Study. Stroke 1996, 27:1274-1282.
27. Englund E: Neuropathology of white matter lesions in vascular cognitive impairment. Cerebrovasc Dis 2002, 13(Suppl 2):11-15.
28. Englund E: Neuropathology of white matter disease: parenchymal changes. In The Matter of White Matter. Clinical and Pathophysiological Aspects of White Matter Disease Related to Cognitive Decline and Vascular Dementia. Edited by Pantoni L, Inzitari D, Wallin A. Utrecht: Academic Pharmaceutical Productions; 2000:223-246.
29. Pantoni L: Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis 2002, 13(Suppl 2):7-10.
30. DeCarli C, Murphy DGM, Tran M, et al.: The effect of white matter hyperintensity volume on brain structure, cognitive performance and cerebral metabolism in 51 healthy adults. Neurology 1995, 45:2077-2084.
31. Schmidt R, Schmidt H, Kapeller P, et al.: Evolution of white matter lesions. Cerebrovasc Dis 2002, 13(Suppl 2): 16-20.
32. Fisher CM, The arterial lesions underlying lacunes, Acta Neuropathol 1969, 3:1-5.
33. Longstreth WT, Diehr P, Manolio TA, et al., for the Cardiovascular Health Study Collaborative Research Group: Cluster analysis and patterns of findings on cranial magnetic resonance imaging of the elderly: the Cardiovascular Health Study. Arch Neurol 2001, 58:635-640.
34. Pantoni L: Cerebral white matter ischemia and anoxia: data from experimental models. In The Matter of White Matter. Clinical and Pathophysiological Aspects of White Matter Disease Related to Cognitive Decline and Vascular Dementia. Edited by Pantoni L, Inzitari D, Wallin A. Utrecht: Academic Pharmaceutical Productions; 2003:377-388.
35. Erkinjuntti T, Haltia M, Palo J, Paetu A: Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatr 1988, 51:1037-1044.
36. Petrovitch H, White LR, Izmirilian G, et al.: Midlife blood pressure and neuritic plaques, neurofibrillary tangles and brain weight at death: the HAAS. Neurobiol Aging 2000, 21:57-62.
37. Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study (MRC CFAS): Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001, 357:169-175.
38. Snowdon DA, Greiner LH, Mortimer JA, et al.: Brain infarction and the clinical expression of Alzheimer's disease. The Nun Study. JAMA 1997, 277:813-817.
39. Kalaria RN: The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000, 21:321-330.
40. Loscalzo J, Balaban R, Becker LB, et al.: Task force on strategic research direction: basic science subgroup key science topics report. Circulation 2002, 106:e149-e161.
41. Strassburger TL, Lee HC, Daley EM, et al.: Interactive effects of age and hypertension on volumes of brain structures. Stroke 1997, 28:1410-1417.
42. Salerno JA, Grady C, Mentis M, et al.: Brain metabolic function in older men with chronic essential hypertension. J Gerontol Biol Sci Med Sci 1995, 50:M147-M154.
43. Psaty BM, Furberg CD, Kuller LH, et al.: Association between blood pressure level and the risk of myocardial infarction, stroke, ad total mortality: the cardiovascular health study. Arch Intern Med 2001, 161:1183-1192.
44. Skoog I, Andreasson LA, Landahl S, Lernfelt B: A Population-based study on blood pressure and brain atrophy in 85-year-olds. Hypertension 1998, 32:404-409.
45. Burke WJ, Coronado PG, Schmitt CA, et al.: Blood pressure regulation in Alzheimer=s disease. J Auton Nerv Syst 1994, 48:65-71.
46. Vinters HV: Cerebral amyloid angiopathy. A critical review. Stroke 1987, 18N:311-324.
47. Pfeifer LA, White LR, Ross GW, et al.: Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study. Neurology 2002, 58:1629-1634.
48. Walker LC, Durham RA: Cerebrovascular amyloidosis: experimental analysis in vitro and in vivo. Histol Histopathol 1999, 14:827-837.
49. de la Torre JC, Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis. Neurobiol Aging 21:331-342.
50. Thomas T, Thomas G, McLendon C, et al.: Beta-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 1996, 380:168-171.